Tracking every rollback, reversal, and overreach — and the path back to the America we know.
The Trump administration announced 100% tariffs on patented drugs to force pharmaceutical companies into pricing negotiations and shift manufacturing to America. This action leverages tariff threats to compel drugmakers into 'most-favored nation' pricing deals. The policy directly impacts drug prices and availability for American consumers while pressuring companies to relocate production domestically.
Executive Order 14387 directs increased domestic production of elemental phosphorus and glyphosate-based herbicides for national defense purposes. The order aims to reduce reliance on foreign suppliers and ensure adequate agricultural chemical supplies. This affects American farmers, agricultural input costs, and domestic chemical manufacturing operations.
President Trump signed Proclamation 2026-01052 adjusting imports of semiconductors, semiconductor manufacturing equipment, and derivative products into the United States. The proclamation modifies tariff classifications and import conditions for these technology products. This affects domestic semiconductor manufacturers, electronics companies, and consumers through potential price increases and supply chain modifications.
Trump signed a proclamation adjusting imports of medium and heavy-duty vehicles, vehicle parts, and buses into the United States. The action imposes tariffs on these vehicle categories, affecting domestic manufacturing and potentially increasing prices for commercial transportation equipment. American businesses relying on imported vehicle components and consumers purchasing commercial vehicles face higher costs.
Trump administration issued Proclamation 2025-14893 adjusting copper import regulations into the United States. The proclamation modifies tariff rates or import quotas on copper products. This action affects domestic copper prices, manufacturing costs for industries reliant on copper, and international trade relations.
President Trump signed Proclamation 2025-13890 on July 17, 2025, providing regulatory relief for certain stationary sources in the chemical manufacturing industry. The action aims to promote American chemical manufacturing security by reducing regulatory burdens on chemical producers. The proclamation directly impacts chemical manufacturers through streamlined compliance requirements and reduced operational costs.
Trump administration issued a memorandum invoking Section 303 of the Defense Production Act to waive statutory requirements for munitions and minerals production. The action prioritizes domestic manufacturing and defense industrial base expansion. This could accelerate mining operations and weapons production while potentially reducing environmental and labor protections.
President Trump signed Executive Order 14289 on April 29, 2025, addressing tariffs on imported articles. The order modifies existing tariff policies affecting goods entering the United States. This action impacts American consumers, businesses reliant on imports, and domestic manufacturing sectors through altered trade costs and supply chain dynamics.
President Trump signed Proclamation 10930 on March 26, 2025, adjusting import duties and tariffs on automobiles and automobile parts entering the United States. The proclamation modifies trade conditions for foreign-made vehicles and components, likely increasing costs for imported cars and affecting domestic auto manufacturing. American consumers may face higher vehicle prices and reduced selection of foreign automobiles.
Executive Order 13944 was signed on August 6, 2020, directing federal agencies to prioritize domestic production of essential medicines, medical countermeasures, and critical inputs needed for public health emergencies. The order established requirements for federal procurement preferences and directed the Department of Health and Human Services and Department of Defense to assess supply chain vulnerabilities and develop strategies to increase domestic manufacturing capacity. Confirmed effects included increased federal contracting focus on domestic suppliers and initiation of supply chain assessments, though full implementation of domestic production expansion occurred over subsequent months.